Blog2017-03-08T08:24:22+01:00

Blog

Use of large language models in clinical research (part 1)

The importance of artificial intelligence (AI) and its potential impact on the workforce has entered the limelight in the last weeks of the year 2022. News outlets and internet websites reported on a groundbreaking achievement in AI: the development of chatbots based on large language models (LLMs) that can be used by the general public in an intuitive, conversational and user-friendly manner

Clinical trials: increasing the visibility of research with visual abstracts

Communication of scientific results to the public is a very important part of research. The new EU CTR also requires that the results are communicated to the general public in a language understandable to lay persons. Furthermore, social media provides great dissemination channels for researchers to attract readers.

By |February 15th, 2023|Categories: 2 Cents on Medicine|Tags: , , , , |

Orphan Drugs in the process of the German Act on the Reform of the Market for Medicinal Products (AMNOG) – Quo Vadis?

The special position of Orphan Drugs in the process of the German Act on the Reform of the Market for Medicinal Products (AMNOG, Arzneimittelneuordnungsgesetz) is frequently criticized. In the following article, we will explain the concept of Orphan Drugs, elaborate their particular role and discuss the upcoming changes within the AMNOG process.

By |October 13th, 2022|Categories: Value Dossier|Tags: , , , |

Artificial Intelligence (AI) in clinical research: transformation of clinical trials and status quo of regulations

Artificial Intelligence (AI) supported technologies play a crucial role in clinical research: For example, during the COVID-19 pandemic the Biotech Company BenevolentAI found through a machine-learning approach that the kinase inhibitor Baricitinib, commonly used to treat arthritis, could also improve COVID-19 outcomes.

By |June 23rd, 2022|Categories: 2 Cents on Medicine|Tags: , , , , , , |
Go to Top